Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
Clinical trial NCT06445114 · RECRUITING
Trial details
- NCT number
- NCT06445114
- Sponsor
- Zachary Zumsteg
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-12
- Primary completion
- 2032-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.